CorMedix Income Statement (2010-2025) | CRMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.09M	0.01M	0.04M	0.06M	0.01M	0.02M	0.01M	0.03M						0.81M	11.46M	31.21M	39.08M	39.74M	104.28M	128.62M
Cost of Revenue (Quarter)	0.06M	0.01M	0.03M	0.05M	0.00M	332.00	0.00M	406.00					0.82M	0.51M	0.63M	1.12M	1.60M	1.86M	7.57M	11.17M
Gross Profit (Quarter)	0.03M	-0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.03M					-0.82M	0.30M	10.77M	30.03M	37.48M	37.87M	93.08M	107.31M
Operating items
Amortization - Intangibles (Quarter)															0.05M	0.05M			3.63M	10.14M
Research & Development (Quarter)	2.64M	2.52M	4.74M	3.24M	2.29M	3.21M	2.34M	2.84M	3.41M	4.79M	4.06M	3.20M	0.84M	7.39M	0.73M	26.52M	3.19M	2.44M	11.19M	-2.71M
Selling, General & Administrative (Quarter)	4.60M	3.36M	3.84M	4.55M	4.75M	5.05M	4.63M	5.58M	7.61M	3.75M	3.74M	5.22M	8.71M	7.56M	6.58M	7.11M	9.69M	9.50M	25.45M	23.57M
Other Operating Expenses (Quarter)										3.26M	2.66M	7.25M	6.34M	0.65M	6.75M	-16.53M	4.47M	6.38M	-2.40M	-4.10M
Operating Expenses (Quarter)	7.24M	5.88M	8.58M	7.79M	7.04M	8.26M	6.97M	8.42M	11.02M	11.80M	10.47M	15.67M	15.89M	15.60M	14.06M	17.10M	17.36M	18.33M	41.73M	48.18M
Operating Income (Quarter)	-7.21M	-5.88M	-8.56M	-7.78M	-7.03M	-8.24M	-6.96M	-8.39M	-11.02M	-11.80M	-10.47M	-15.67M	-16.70M	-15.30M	-3.29M	12.94M	20.13M	19.54M	51.35M	59.13M
EBIT (Quarter)	-7.21M	-5.88M	-8.56M	-7.78M	-7.03M	-8.24M	-6.96M	-8.39M	-11.02M	-11.80M	-10.47M	-15.67M	-16.70M	-15.30M	-3.29M	12.94M	20.13M	19.54M	51.35M	59.13M
Non-operating items
Non Operating Investment Income (Quarter)																			3.09M	2.27M
Interest & Investment Income (Quarter)	0.00M	0.00M	0.00M	0.00M	0.01M	0.04M	0.02M	0.18M	0.45M	-0.01M	0.77M	2.68M	0.86M	0.00M	0.01M	2.58M	-0.00M	-0.00M	0.01M	3.84M
Other Non Operating Income (Quarter)	-0.01M	-893.00	-0.00M	-0.01M	-0.00M	0.02M	0.02M	0.31M	0.01M	0.53M	-0.03M	0.00M	-0.00M	0.50M	-0.03M	0.56M	-0.04M	-0.02M	-0.07M	0.08M
Non Operating Income (Quarter)											0.72M	0.91M	0.84M	1.15M	0.51M	0.53M	0.52M	0.81M	1.23M	-2.68M
Net income details
EBT (Quarter)	-17.26M	-5.88M	-8.57M	-7.79M	-8.16M	-8.19M	-6.85M	-8.21M	-10.57M	-11.27M	-9.74M	-14.75M	-15.86M	-14.15M	-2.78M	13.46M	20.64M	20.35M	52.58M	56.45M
Tax Provisions (Quarter)		-1.25M		1.88M		-0.59M							-1.39M	-0.01M	0.01M	-230.00		0.52M	-55.99M	68.22M
Profit After Tax (Quarter)	-7.22M	-4.63M	-8.57M	-7.79M	-7.07M	-7.60M	-6.85M	-8.21M	-10.55M	-11.27M	-9.75M	-14.74M	-0.01M	-14.15M	-2.78M	0.00M	-0.01M	-0.01M	0.01M	-1.79M
Income from Non-Controlling Interests (Quarter)													14.48M	14.15M	2.77M	-13.47M	-20.64M	-19.82M	-108.57M	-13.94M
Income from Continuing Operations (Quarter)	-17.26M	-4.63M	-8.57M	-9.67M	-8.16M	-7.60M	-6.85M	-8.21M	-10.57M	-11.27M	-9.74M	-14.75M	-14.47M	-14.15M	-2.78M	13.46M	20.64M	19.83M	108.56M	-11.78M
Consolidated Net Income (Quarter)	-17.26M	-4.63M	-8.57M	-9.67M	-8.16M	-7.60M	-6.85M	-8.21M	-10.57M	-11.27M	-9.74M	-14.75M	-14.47M	-14.15M	-2.78M	13.46M	20.64M	19.83M	108.56M	-11.78M
Income towards Parent Company (Quarter)	-17.26M	-4.63M	-8.57M	-9.67M	-8.16M	-7.60M	-6.85M	-8.21M	-10.57M	-11.27M	-9.74M	-14.75M	-14.47M	-14.15M	-2.78M	13.46M	20.64M	21.86M	108.53M	-11.78M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	7.20M	4.60M	8.60M	-9.67M	7.00M	7.60M	-6.85M	-8.21M	-10.57M	-11.27M	-9.74M	-14.75M	-14.47M	-14.15M	-2.78M	13.46M	20.64M	21.86M	108.53M	-11.78M
Additional items
EPS (Basic) (Quarter)	0.20	0.12	0.23	-0.26	0.18	0.19	-0.17	-0.20	-0.24	-0.25	-0.17	-0.29	-0.25	-0.25	-0.05	0.23	0.32	0.32	1.42	-18.37
EPS (Diluted) (Quarter)	0.40	0.12	0.23	-0.26	0.18	0.19	-0.17	-0.20	-0.24	-0.25	-0.17	-0.29	-0.25	-0.25	-0.05	0.23	0.30	0.30	1.26	-146.65
Shares Outstanding (Quarter)	36.33M	38.08M	38.11M	37.67M	38.25M	39.76M	41.18M	40.27M	44.09M	45.37M	56.55M	50.90M	57.50M	57.62M	58.83M	58.87M	65.24M	67.93M	76.40M	0.64M
Shares Outstanding (Diluted) (Quarter)	17.82M	38.08M	38.11M	37.67M	38.25M	39.76M	41.18M	40.27M	44.09M	45.37M	56.55M	50.90M	57.50M	57.62M	58.83M	58.87M	68.98M	71.92M	86.21M	0.08M
Shares Outstanding (Entity) (Quarter)	38.05M	38.09M	38.09M	38.09M	38.73M	41.11M	41.21M	42.82M	44.50M	45.81M	54.81M	54.94M	54.96M	55.27M	57.89M	64.41M	67.71M	67.93M
EBITDA (Quarter)	-7.21M	-5.88M	-8.56M	-7.78M	-7.03M	-8.24M	-6.96M	-8.39M	-11.02M	-11.80M	-10.47M	-15.67M	-16.70M	-15.30M	-3.29M	12.94M	20.13M	19.54M	51.35M	59.13M
Interest Expenses (Quarter)	10.05M	2.87M	0.95M	0.01M	1.14M	0.00M	0.05M	0.18M	0.05M	0.05M	0.05M	0.01M	0.17M	0.17M	0.05M	-0.12M	0.53M	2.39M	280.00M	2.57M
Tax Rate (Quarter)		21.25%		-24.08%		7.15%							8.79%	0.04%	-0.19%	0.00%		2.56%	-106.49%	120.86%

Research Tools

Developers

CorMedix Income Statement (2010-2025) | CRMD

Research Tools

Developers

CorMedix Income Statement (2010-2025) | CRMD

Create an account

Sign In

Reset Password